TEN BAY BIO, INC.

Profile

Company Names

TEN BAY BIO, INC.

Addresses

4816 W. WISCONSIN AVENUE, MILWAUKEE, WI 53208

4816 W WISCONSIN AVE, MILWAUKEE, WI 53208

Phone Numbers

(262) 492-5557

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2024

State Incorporated:

DELAWARE

Total Amount Raised:

$11,549,996.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-07-23 
$11,549,996.00 
$11,549,996.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CASEY 
 
CUNNINGHAM 
DIRECTOR
TERAPIO CORP   |  MOLECULAR TEMPLATES, INC.   |  ABVITRO INC   |  BETA CAT PHARMACEUTICALS, INC.   |  LYRIC PHARMACEUTICALS INC.   |  GENEOS THERAPEUTICS, INC.   |  GLYSCEND, INC.   |  SEEING MEDICINES, INC.   |  TEN BAY BIO, INC.
ANDREW 
 
KADLEC 
EXECUTIVE OFFICER, DIRECTOR
TEN BAY BIO, INC.
OMAR 
 
KHALIL 
DIRECTOR
SEEING MEDICINES, INC.   |  KESTREL THERAPEUTICS INC.   |  TEN BAY BIO, INC.
TIM 
 
MAYLEBEN 
DIRECTOR
LYCERA CORP   |  DENOVO SCIENCES, INC.   |  SOLULINK INC   |  TEN BAY BIO, INC.
PAUL 
 
WEISS 
DIRECTOR
EUTHYMICS BIOSCIENCE INC   |  PIPELINE FINANCE LLC   |  AKEBIA THERAPEUTICS, INC.   |  GINNIE ACCEPTANCE COMPANY, LLC   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  WEST HILL STRATEGIC BOND FUND, LP   |  EUTHYMICS BIOSCIENCE, INC.   |  FLUGEN INC   |  INVENRA INC.   |  VENTURE INVESTORS HEALTH FUND 6 LIMITED PARTNERSHIP   |  TEN BAY BIO, INC.   |  VENTURE INVESTORS HEALTH FUND 7 LIMITED PARTNERSHIP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-13
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-23 
2024-08-06
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#